32.25
Oscar Health Inc stock is traded at $32.25, with a volume of 3.67M.
It is up +0.03% in the last 24 hours and up +6.16% over the past month.
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
See More
Previous Close:
$32.24
Open:
$32.19
24h Volume:
3.67M
Relative Volume:
0.63
Market Cap:
$9.95B
Revenue:
$13.30B
Net Income/Loss:
$-39.39M
P/E Ratio:
-52.90
EPS:
-0.6096
Net Cash Flow:
$2.80B
1W Performance:
+5.84%
1M Performance:
+6.16%
6M Performance:
+114.29%
1Y Performance:
+75.46%
Oscar Health Inc Stock (OSCR) Company Profile
Name
Oscar Health Inc
Sector
Industry
Phone
(646) 403-3677
Address
75 VARICK STREET, NEW YORK
Compare OSCR vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
OSCR
Oscar Health Inc
|
32.25 | 9.74B | 13.30B | -39.39M | 2.80B | -0.6096 |
|
UNH
Unitedhealth Group Inc
|
397.14 | 345.44B | 450.13B | 14.91B | 23.62B | 15.55 |
|
CVS
Cvs Health Corp
|
96.74 | 119.78B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
ELV
Elevance Health Inc
|
407.50 | 85.94B | 201.11B | 4.95B | 6.29B | 22.50 |
|
CI
Cigna Group
|
282.52 | 72.51B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
401.54 | 45.72B | 137.20B | 1.15B | 1.27B | 9.3439 |
Oscar Health Inc Stock (OSCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-10-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-04-26 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-06-26 | Initiated | Wolfe Research | Peer Perform |
| Apr-20-26 | Upgrade | Jefferies | Underperform → Hold |
| Feb-12-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-09-26 | Upgrade | UBS | Sell → Neutral |
| Jan-05-26 | Upgrade | Barclays | Underweight → Equal Weight |
| Dec-11-25 | Initiated | Stephens | Equal-Weight |
| Nov-26-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-14-25 | Initiated | Goldman | Neutral |
| Jul-25-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jul-15-25 | Downgrade | UBS | Neutral → Sell |
| Jul-14-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-11-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jul-02-25 | Initiated | Barclays | Underweight |
| Jun-24-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-13-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-24 | Initiated | Jefferies | Underperform |
| Nov-06-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-07-24 | Initiated | UBS | Neutral |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| May-30-24 | Downgrade | BofA Securities | Buy → Neutral |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-22-24 | Initiated | Raymond James | Outperform |
| Nov-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-06-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Nov-16-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-15-22 | Downgrade | BofA Securities | Neutral → Underperform |
| May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-14-22 | Downgrade | Goldman | Neutral → Sell |
| Jan-06-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-14-21 | Initiated | Goldman | Sell |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Mar-30-21 | Initiated | Wells Fargo | Overweight |
| Mar-29-21 | Initiated | BofA Securities | Buy |
| Mar-29-21 | Initiated | Cowen | Market Perform |
| Mar-29-21 | Initiated | Credit Suisse | Outperform |
| Mar-29-21 | Initiated | Goldman | Buy |
| Mar-29-21 | Initiated | Morgan Stanley | Overweight |
View All
Oscar Health Inc Stock (OSCR) Latest News
Wellington Management Group LLP Boosts Position in Oscar Health, Inc. $OSCR - MarketBeat
37,136 Shares in Oscar Health, Inc. $OSCR Acquired by AXQ Capital LP - MarketBeat
OSCR Stock Hits 5-Year High: Oscar Sees 'Healthy Tailwinds' In 2026 On Potential Upside To Guidance - Stocktwits
Oscar Health Stock Price Forecast. Should You Buy OSCR? - StockInvest.us
Oscar Health (NYSE:OSCR): Is This Momentum Rally Built to Last? - Kalkine Media
Oscar Health, Inc. (OSCR) Just Overtook the 20-Day Moving Average - Zacks Investment Research
Oscar Health, Inc. (OSCR) Just Overtook the 50-Day Moving Average - Yahoo Finance
Oscar Health (NYSE:OSCR) Displays High Growth Momentum With a Defined Breakout Setup - ChartMill
Best Growth Stocks to Buy for September 4th - Zacks Investment Research
Oscar Health, Inc. (NYSE:OSCR) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Oscar Health Inc (OSCR) Shares Surge 6.3% -- What GF Score of 82 Tells Investors - GuruFocus
Oscar Health (NYSE: OSCR) officer plans $286K stock sale - Stock Titan
Oscar Health (NYSE: OSCR) insider plans new stock sale - Stock Titan
Oscar Health (OSCR) holder lines up $326K stock sale - Stock Titan
Oscar Health (NYSE: OSCR) officer plans $908K Rule 144 share sale - Stock Titan
Oscar Health, Inc. • Robinhood Token (OSCR) Price Prediction for 2026 to 2031 - Bybit
Oscar Health Membership Surges but Profitability Remains Key - Yahoo Finance
Oscar Health Skyrockets 109% YTD: Time to Bet on the Stock Now? - TradingView
Oscar Health, Inc. (OSCR) Stock Price & News - Syfe
Mario Schlosser Sells 600,000 Shares of Oscar Health (NYSE:OSCR) Stock - MarketBeat
Mario Schlosser Sells 150,000 Shares of Oscar Health (NYSE:OSCR) Stock - MarketBeat
Oscar Health, Inc. (OSCR) Stock Analysis: Is the Recent 70.4% Revenue Growth a Sign of More to Come? - DirectorsTalk Interviews
Is Oscar Health (OSCR) Fully Priced Following Raised 2026 Guidance? - Yahoo Finance
Oscar Health (NYSE:OSCR) Trading 4.4% HigherWhat's Next? - MarketBeat
Oscar Health (NYSE: OSCR) holder plans $4.6M share sale - Stock Titan
Oscar Health Inc (OSCR) Stock Down 3.8% but Still Overvalued -- GF Score: 82/100 - GuruFocus
Oscar Health (NYSE: OSCR) faces new Mario Schlosser stock sale - Stock Titan
Fast-paced Momentum Stock Oscar Health (OSCR) Is Still Trading at a Bargain - Yahoo Finance
Oscar Health (NYSE:OSCR) Reaches New 12-Month HighHere's Why - MarketBeat
Oscar Health CFO Blackley sells $595,125 in shares By Investing.com - Investing.com South Africa
Oscar Health (NYSE:OSCR) CFO Sells 18,750 Shares - MarketBeat
Oscar Health CFO Blackley sells $595,125 in shares - Investing.com
Oscar Health Insider Sold Shares Worth $595,125, According to a Recent SEC Filing - marketscreener.com
Oscar Health (NYSE: OSCR) ex-affiliate plans multi-million stock sale - Stock Titan
HIMS Stock Climbs Overnight: Oscar Health CEO Courts Hims For New Drug Marketplace - Stocktwits
Oscar Health Stock Analysis: Buy or Sell? - The Globe and Mail
Oscar Health (OSCR) CFO lines up new stock sale after recent $2.75M sale - Stock Titan
OSCR Q2 2026 Earnings: Massive EPS Beat Lifts Sentiment Amid Strategic GrowthGeographic Revenue Trends - Vinanet
Oscar Health Inc (OSCR) Stock Down 3.7% but Still Overvalued -- GF Score: 82/100 - GuruFocus
OSCR Q2 2026 Earnings: EPS of $1.10 Surges Past Estimates by 179.5%ROIC Trend Report - Vinanet
OSCR Looks 37.8% Overvalued on GF Value™ as Momentum and Growth Shine - GuruFocus
Oscar Health, Inc. (OSCR) Investor Outlook: Evaluating Strong Revenue Growth Amid High RSI Levels - DirectorsTalk Interviews
Empowered Funds LLC Invests $6.23 Million in Oscar Health, Inc. $OSCR - MarketBeat
Oscar Health (OSCR) Is Up 17.4% After Swinging To Profit And Raising 2026 GuidanceWhat's Changed - simplywall.st
Royal Bank of Canada Acquires 119,714 Shares of Oscar Health, Inc. $OSCR - MarketBeat
Oscar Health, Inc. $OSCR Shares Purchased by Bank of America Corp DE - MarketBeat
OSCR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is Oscar Health (OSCR) Undervalued After Its Earnings Beat And Guidance Raise? - Yahoo Finance
Can Oscar Health (OSCR) Still Look Cheap After Strong Q2? - Yahoo Finance
Oscar Health’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Oscar Health (NYSE:OSCR) Reaches New 52-Week HighTime to Buy? - MarketBeat
Oscar Health Inc Stock (OSCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):